Investor
KHAN Technology Transfer Fund II
Dortmund · Germany
Early-stage life sciences venture fund focused on first-in-class therapies and drug development partnerships with academic innovators in Europe.
Stage
Pre-seed–Seed
Sectors
2 sectors
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
About
This firm is an early-stage life sciences venture fund. It focuses on first-in-class therapies for attractive markets with a high unmet medical need. The firm aims to translate academic projects into commercially viable assets. It manages over €130 million to create value through cooperative drug development partnerships with academic innovators in Europe. The team focuses on proof of concept, pre-seed, and seed stages, targeting scientific assets and equity investments.
Portfolio · 5 · tap a company to read about it